Sök i LIBRIS databas

  Utökad sökning


Sökning: onr:"swepub:oai:research.chalmers.se:609aa7a9-f127-44a4-bcd8-9cc82263e342" > Pre-diagnostic plas...

Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort

Eriksen, Anne K. (författare)
Danish Cancer Research Society Center, Denmark
Kyro, C. (författare)
Danish Cancer Research Society Center, Denmark
Nørskov, N. (författare)
Aarhus University, Denmark
visa fler...
Frederiksen, Kirsten (författare)
Danish Cancer Research Society Center, Denmark
Bach Knudsen, Knud Erik (författare)
Aarhus University, Denmark
Overvad, K. (författare)
Aarhus University, Denmark
Landberg, Rikard, 1981 (författare)
Chalmers University of Technology,Chalmers tekniska högskola
Tjønneland, Anne (författare)
University of Copenhagen, Denmark,Danish Cancer Research Society Center, Denmark
Olsen, Anja (författare)
Danish Cancer Research Society Center, Denmark
visa färre...
Ingår i: Diabetologia. - 1432-0428 .- 0012-186X.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
  • Aims/hypothesis: The phytoestrogen enterolactone is a gut microbiota-derived metabolite of plant lignans with suggested beneficial properties for health. In the current study, we investigated the association between pre-diagnostic plasma enterolactone concentrations and mortality among individuals diagnosed with type 2 diabetes. Methods: In a population of people diagnosed with diabetes, nested within the Danish Diet, Cancer and Health cohort, we conducted a case-cohort study including a random sample of n = 450 cases (deceased) and a randomly selected subcohort of n = 850 (in total n = 617 deaths). Information on diagnosis, vital status and cause of death was obtained from Danish registers. Cox proportional hazard models with special weighting were applied to assess all-cause and cause-specific mortality. Results: The median enterolactone concentration of the current population was low, 10.9 nmol/l (5th percentile to 95th percentile: 1.3–59.6), compared with previously reported concentrations from the Diet, Cancer and Health cohort. Pre-diagnostic enterolactone concentrations were associated with lower all-cause mortality when assessed linearly per doubling in concentration (log 2 ) (HR 0.91 [95% CI 0.85, 0.96]) and according to quartiles (HR 0.63 [95% CI 0.48, 0.84]) for the highest quartile of enterolactone compared with the lowest quartile. For cause-specific mortality, only death from diabetes (registered as underlying cause of death) reached statistical significance. Conclusions/interpretation: Based on this large cohort of people with diabetes with detailed and complete baseline and follow-up information, pre-diagnostic enterolactone concentrations were inversely associated with mortality. To our knowledge, this is the first study on enterolactone and type 2 diabetes mortality. Our findings call for further exploration of enterolactone in type 2 diabetes management.


MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences (hsv//eng)


Type 2 diabetes

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy